{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:49:27Z","timestamp":1791452967298,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"DOI":"10.1007\/s12072-026-11161-w","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:53:34Z","timestamp":1791449614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristic geoepidemiology and phenotype of autoimmune hepatitis: an 8-year population-based study in Taiwan"],"prefix":"10.1007","author":[{"given":"Jur-Shan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Feng","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Huan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Pin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chung","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-4401","authenticated-orcid":false,"given":"Ming-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"1","key":"11161_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354(1):54\u201366","journal-title":"N Engl J Med"},{"issue":"1","key":"11161_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/cld.798","volume":"14","author":"C Lammert","year":"2019","unstructured":"Lammert C. Genetic and environmental risk factors for autoimmune hepatitis. Clin Liver Dis. 2019;14(1):29\u201332","journal-title":"Clin Liver Dis"},{"issue":"9","key":"11161_CR3","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/2050640619872408","volume":"7","author":"S Pape","year":"2019","unstructured":"Pape S, Schramm C, Gevers TJ. Clinical management of autoimmune hepatitis. United Eur Gastroenterol J. 2019;7(9):1156\u20131163","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"11161_CR4","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jhep.2020.07.023","volume":"73","author":"AW Lohse","year":"2020","unstructured":"Lohse AW, Sebode M, J\u00f8rgensen MH, Ytting H, Karlsen TH, Kelly D, et al. Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. J Hepatol. 2020;73(6):1496\u20131506","journal-title":"J Hepatol"},{"issue":"3","key":"11161_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","volume":"6","author":"KM Boberg","year":"2002","unstructured":"Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis. 2002;6(3):635\u2013647","journal-title":"Clin Liver Dis"},{"key":"11161_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102280","volume":"65","author":"JW Hahn","year":"1970","unstructured":"Hahn JW, Yang HR, Moon JS, Chang JY, Lee K, Kim GA, et al. Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis. EClinicalMedicine. 1970;65: 102280","journal-title":"EClinicalMedicine"},{"issue":"12","key":"11161_CR7","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.cgh.2021.01.029","volume":"19","author":"GJ Webb","year":"2021","unstructured":"Webb GJ, Ryan RP, Marshall TP, Hirschfield GM. The epidemiology of UK autoimmune liver disease varies with geographic latitude. Clin Gastroenterol Hepatol. 2021;19(12):2587\u20132596","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"11161_CR8","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/jgh.14746","volume":"34","author":"T Lv","year":"2019","unstructured":"Lv T, Li M, Zeng N, Zhang J, Li S, Chen S, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol. 2019;34(10):1676\u20131684","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"11161_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12072-024-10761-8","volume":"19","author":"JW Wu","year":"2025","unstructured":"Wu JW, Chen WT, Huang CG, Chen YC, Hsu CW, Chien RN, et al. Rheumatoid factor levels indicate cryoglobulinemia severity in hepatitis B e antigen-negative hepatitis B virus carriers: a 7-year prospective cohort study. Hepatol Int. 2025;19(1):118\u2013130","journal-title":"Hepatol Int"},{"issue":"6","key":"11161_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12072-025-10906-3","volume":"19","author":"ML Chang","year":"2025","unstructured":"Chang ML, Cheng JS, Tai J, Chen WT, Yang SS, Chiu CH, et al. Paradoxical association between steatotic liver disease and favorable hepatic outcomes in HCV patients with SVRs. Hepatol Int. 2025;19(6):1347\u20131359","journal-title":"Hepatol Int"},{"issue":"12","key":"11161_CR11","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/j.cgh.2020.10.006","volume":"19","author":"R Sharma","year":"2021","unstructured":"Sharma R, Verna EC, S\u00f6derling J, Roelstraete B, Hagstr\u00f6m H, Ludvigsson JF. Increased mortality risk in autoimmune hepatitis: a nationwide population-based cohort study with histopathology. Clin Gastroenterol Hepatol. 2021;19(12):2636-2647.e13","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"11161_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/liv.13236","volume":"37","author":"GW Wong","year":"2017","unstructured":"Wong GW, Yeong T, Lawrence D, Yeoman AD, Verma S, Heneghan MA. Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes. Liver Int. 2017;37(3):449\u2013457","journal-title":"Liver Int"},{"issue":"9","key":"11161_CR13","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.cgh.2020.01.018","volume":"18","author":"ML Chang","year":"2020","unstructured":"Chang ML, Cheng JS, Chien RN, Liaw YF. Hepatitis flares are associated with better outcomes than no flare in patients with decompensated cirrhosis and chronic hepatitis B virus infection. Clin Gastroenterol Hepatol. 2020;18(9):2064-2072.e2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11161_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823160","volume":"13","author":"ML Chang","year":"2022","unstructured":"Chang ML, Cheng JS, Chuang YH, Pao LH, Wu TS, Chen SC, et al. Evolution of cryoglobulinemia in direct-acting antiviral-treated Asian hepatitis C patients with sustained virological responses: a 4-year prospective cohort study. Front Immunol. 2022;13: 823160","journal-title":"Front Immunol"},{"issue":"18","key":"11161_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003546","volume":"95","author":"JH Hu","year":"2016","unstructured":"Hu JH, Chen MY, Yeh CT, Lin HS, Lin MS, Huang TJ, et al. Sexual dimorphic metabolic alterations in hepatitis C virus-infected patients: a community-based study in a hepatitis B\/hepatitis C virus hyperendemic area. Medicine (Baltimore). 2016;95(18): e3546","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"11161_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2470128","volume":"14","author":"ML Chang","year":"2025","unstructured":"Chang ML, Cheng JS, Chen WT, Shen YJ, Kuo CJ, Chien RN. Mixed cryoglobulinemia decelerates hepatocellular carcinoma development in hepatitis C patients with SVR by downregulating regulatory B cells: a 12-year prospective cohort study. Oncoimmunology. 2025;14(1): 2470128","journal-title":"Oncoimmunology"},{"issue":"6","key":"11161_CR17","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s10620-024-08439-0","volume":"69","author":"ML Chang","year":"2024","unstructured":"Chang ML, Le PH, Chen WT, Chen TD, Chien RN. Hepatic and extrahepatic characteristics of autoimmune hepatitis: a 23-year hospital-based cohort study. Dig Dis Sci. 2024;69(6):2193\u20132203","journal-title":"Dig Dis Sci"},{"issue":"12","key":"11161_CR18","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1111\/jgh.16736","volume":"39","author":"ML Chang","year":"2024","unstructured":"Chang ML, Le PH, Chen WT, Chen TD, Su CW, Chen CJ, et al. Distinct characteristics of various autoimmune liver diseases: a 22-year hospital-based study in Taiwan. J Gastroenterol Hepatol. 2024;39(12):2835\u20132844","journal-title":"J Gastroenterol Hepatol"},{"key":"11161_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241241227","volume":"17","author":"ML Chang","year":"2024","unstructured":"Chang ML, Cheng JS, Le PH, Chen WT, Ku HP, Chien RN. Evolutionary relationship between antimitochondrial antibody positivity and primary biliary cholangitis in Taiwan: a 16-year hospital cohort study. Therap Adv Gastroenterol. 2024;17: 17562848241241227","journal-title":"Therap Adv Gastroenterol"},{"issue":"9","key":"11161_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/hepr.13910","volume":"53","author":"JS Cheng","year":"2023","unstructured":"Cheng JS, Chen WT, Ku HP, Chien RN, Chang ML. Characteristic geoepidemiology of primary biliary cholangitis in Taiwan: a nationwide population-based study. Hepatol Res. 2023;53(9):866\u2013877","journal-title":"Hepatol Res"},{"key":"11161_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.70177","author":"JS Cheng","year":"2026","unstructured":"Cheng JS, Chen WT, Chen TH, Lin WP, Chen CJ, Su CW, et al. Medical costs increase over time for primary biliary cholangitis patients: a 20-year population-based study. Hepatol Res. 2026. https:\/\/doi.org\/10.1111\/hepr.70177","journal-title":"Hepatol Res"},{"issue":"10","key":"11161_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101524","volume":"7","author":"J Yang","year":"2025","unstructured":"Yang J, Yim SY, Kim K, Lee HW, Choi J. Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia. JHEP Rep. 2025;7(10): 101524","journal-title":"JHEP Rep"},{"issue":"1","key":"11161_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71296-0","volume":"10","author":"A Takahashi","year":"2020","unstructured":"Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, et al. Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan. Sci Rep. 2020;10(1): 14250","journal-title":"Sci Rep"},{"issue":"11","key":"11161_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101546","volume":"7","author":"C Corpechot","year":"2025","unstructured":"Corpechot C, Hornus P, Cals M, Rinder P, Marcille T, Malek A, et al. Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: a French nationwide study. JHEP Rep. 2025;7(11): 101546","journal-title":"JHEP Rep"},{"issue":"1","key":"11161_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","volume":"80","author":"F Colapietro","year":"2024","unstructured":"Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ, et al. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis. J Hepatol. 2024;80(1):53\u201361","journal-title":"J Hepatol"},{"issue":"8","key":"11161_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","volume":"15","author":"A Tansel","year":"2017","unstructured":"Tansel A, Katz LH, El-Serag HB, Thrift AP, Parepally M, Shakhatreh MH, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(8):1207-1217.e4","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"11161_CR27","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","volume":"70","author":"PJ Trivedi","year":"2021","unstructured":"Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70(10):1989\u20132003","journal-title":"Gut"},{"issue":"11","key":"11161_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000824","volume":"9","author":"J Yao","year":"2025","unstructured":"Yao J, Jiang SF, Kapoor C, Balasubramanian S, Ramalingam ND, Saxena V, et al. The prevalence of autoimmune hepatitis is rising: estimates and trends from a large, multi-ethnic cohort in the United States. Hepatol Commun. 2025;9(11): e0824","journal-title":"Hepatol Commun"},{"issue":"8","key":"11161_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/hepr.13342","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Mori M, Matsumoto K, Ohira H, Tazuma S, Takikawa H. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res. 2019;49(8):881\u2013889","journal-title":"Hepatol Res"},{"issue":"2","key":"11161_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/hep.32653","volume":"77","author":"T Bittermann","year":"2023","unstructured":"Bittermann T, Lewis JD, Levy C, Goldberg DS. Sociodemographic and geographic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis. Hepatology. 2023;77(2):367\u2013378","journal-title":"Hepatology"},{"key":"11161_CR31","unstructured":"https:\/\/latitudelongitude.org\/tw\/. Accessed 27 Sep 2026"},{"key":"11161_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.115449","volume":"224","author":"D Piovani","year":"2023","unstructured":"Piovani D, Brunetta E, Bonovas S. UV radiation and air pollution as drivers of major autoimmune conditions. Environ Res. 2023;224: 115449","journal-title":"Environ Res"},{"issue":"Suppl 1","key":"11161_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00535-010-0337-y","volume":"46","author":"K Migita","year":"2011","unstructured":"Migita K, Watanabe Y, Jiuchi Y, Nakamura Y, Saito A, Yagura M, et al. Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study. J Gastroenterol. 2011;46(Suppl 1):56\u201362. https:\/\/doi.org\/10.1007\/s00535-010-0337-y","journal-title":"J Gastroenterol"},{"key":"11161_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.04.034","author":"CD Slooter","year":"2025","unstructured":"Slooter CD, Troyer IDM, van den Brand FF, de Vries R, Heymans MW, Heneghan MA, et al. Early prognostic factors for reduced survival in autoimmune hepatitis: a systematic review with meta-analysis. Clin Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.cgh.2025.04.034","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11161_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389\u201397.e10","journal-title":"Gastroenterology"},{"key":"11161_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2376231","author":"L Guo","year":"2017","unstructured":"Guo L, Zhou L, Zhang N, Deng B, Wang B. Extrahepatic autoimmune diseases in patients with autoimmune liver diseases: a phenomenon neglected by gastroenterologists. Gastroenterol Res Pract. 2017. https:\/\/doi.org\/10.1155\/2017\/2376231","journal-title":"Gastroenterol Res Pract"},{"issue":"23","key":"11161_CR37","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3748\/wjg.v28.i23.2527","volume":"28","author":"CR Wang","year":"2022","unstructured":"Wang CR, Tsai HW. Autoimmune liver diseases in systemic rheumatic diseases. World J Gastroenterol. 2022;28(23):2527\u20132545","journal-title":"World J Gastroenterol"},{"issue":"3","key":"11161_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","volume":"60","author":"L Gr\u00f8nb\u00e6k","year":"2014","unstructured":"Gr\u00f8nb\u00e6k L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60(3):612\u2013617","journal-title":"J Hepatol"},{"issue":"5","key":"11161_CR39","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s12072-024-10727-w","volume":"18","author":"K Liu","year":"2024","unstructured":"Liu K, Feng M, Chi W, Cao Z, Wang X, Ding Y, et al. Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitis. Hepatol Int. 2024;18(5):1528\u20131539","journal-title":"Hepatol Int"},{"issue":"3","key":"11161_CR40","volume":"16","author":"S Malakar","year":"2024","unstructured":"Malakar S, Mohindra S, Mishra P, Kothalkar S, Shirol VV, Borah G, et al. Implications of gender on the outcome in patients with autoimmune hepatitis. Cureus. 2024;16(3): e55477","journal-title":"Cureus"},{"issue":"5","key":"11161_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00535-011-0519-2","volume":"47","author":"T Hino-Arinaga","year":"2012","unstructured":"Hino-Arinaga T, Ide T, Kuromatsu R, Miyajima I, Ogata K, Kuwahara R, et al. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. J Gastroenterol. 2012;47(5):569\u2013576","journal-title":"J Gastroenterol"},{"issue":"2","key":"11161_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70007","volume":"45","author":"I Lasyte","year":"2025","unstructured":"Lasyte I, Widman L, Bergquist A, Hagstr\u00f6m H. Mortality in autoimmune liver disease in Sweden: a population-based cohort study of 9,654 patients. Liver Int. 2025;45(2): e70007","journal-title":"Liver Int"},{"issue":"1","key":"11161_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03204-z","volume":"24","author":"T Tadokoro","year":"2024","unstructured":"Tadokoro T, Nomura T, Fujita K, Manabe T, Takuma K, Nakahara M, et al. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients. BMC Gastroenterol. 2024;24(1): 123","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"11161_CR44","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.dld.2019.01.015","volume":"51","author":"L Puustinen","year":"2019","unstructured":"Puustinen L, Barner-Rasmussen N, Pukkala E, F\u00e4rkkil\u00e4 M. Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: a nationwide register-based cohort study in Finland. Dig Liver Dis. 2019;51(9):1294\u20131299","journal-title":"Dig Liver Dis"},{"issue":"3","key":"11161_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/apt.70188","volume":"62","author":"S Flatley","year":"2025","unstructured":"Flatley S, Dixon S, Pilsworth E, Dube A, Hoeroldt B, Harrison L, et al. Diabetes mellitus in patients with autoimmune hepatitis: frequency, risk factors and effect on outcome. Aliment Pharmacol Ther. 2025;62(3):319\u2013329","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"11161_CR46","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1111\/liv.15382","volume":"42","author":"R Birn-Rydder","year":"2022","unstructured":"Birn-Rydder R, Jensen MD, Jepsen P, Gr\u00f8nbaek L. Extrahepatic autoimmune diseases in autoimmune hepatitis: effect on mortality. Liver Int. 2022;42(11):2466\u20132472","journal-title":"Liver Int"},{"issue":"10","key":"11161_CR47","first-page":"869","volume":"13","author":"D Zhao","year":"2025","unstructured":"Zhao D, Wu GY. Autoimmune hepatitis associated with other autoimmune diseases: a critical review. J Clin Transl Hepatol. 2025;13(10):869\u2013877","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"11161_CR48","first-page":"522","volume":"55","author":"JH Ngu","year":"2012","unstructured":"Ngu JH, Gearry RB, Frampton CM, Stedman CA. Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury. New Zealand Hepatol. 2012;55(2):522\u2013529","journal-title":"New Zealand Hepatol"},{"key":"11161_CR49","first-page":"209","volume":"98","author":"WT Lin","year":"1999","unstructured":"Lin WT, Lin SJ, Ni YH, Chen HL, Wang HP, Chu JS, et al. Primary sclerosing cholangitis in a child. J Formos Med Assoc. 1999;98:209\u2013213","journal-title":"J Formos Med Assoc"},{"issue":"7","key":"11161_CR50","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1111\/dom.15622","volume":"26","author":"ML Chang","year":"2024","unstructured":"Chang ML, Tai J, Cheng JS, Chen WT, Yang SS, Chiu CH, et al. Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: a 3-year prospective cohort study. Diabetes Obes Metab. 2024;26(7):2969\u20132978","journal-title":"Diabetes Obes Metab"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11161-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:53:36Z","timestamp":1791449616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-026-11161-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":50,"alternative-id":["11161"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11161-w","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JSC, KFS, CHW, CWS, CJC, CYL, THC, WTC, WPL, YCH, JT, YTC, MLC:\u00a0None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}